MOLETI, MARIA LUISA
 Distribuzione geografica
Continente #
NA - Nord America 2.423
EU - Europa 1.827
AS - Asia 1.784
SA - Sud America 248
AF - Africa 103
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.388
Nazione #
US - Stati Uniti d'America 2.352
IT - Italia 1.113
SG - Singapore 708
CN - Cina 257
HK - Hong Kong 230
VN - Vietnam 227
BR - Brasile 184
SE - Svezia 151
IN - India 150
DE - Germania 124
FI - Finlandia 72
FR - Francia 70
GB - Regno Unito 60
CA - Canada 50
JP - Giappone 50
RU - Federazione Russa 43
ZA - Sudafrica 40
NL - Olanda 38
BD - Bangladesh 37
AR - Argentina 32
MA - Marocco 25
UA - Ucraina 23
IQ - Iraq 18
RO - Romania 17
AT - Austria 15
BG - Bulgaria 15
TG - Togo 15
IE - Irlanda 14
ES - Italia 13
ID - Indonesia 12
PH - Filippine 12
PK - Pakistan 12
MX - Messico 11
TR - Turchia 11
PL - Polonia 10
KR - Corea 9
LT - Lituania 9
MY - Malesia 9
CH - Svizzera 8
KE - Kenya 8
SA - Arabia Saudita 8
VE - Venezuela 8
BE - Belgio 6
TN - Tunisia 5
UY - Uruguay 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
EC - Ecuador 4
PT - Portogallo 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HU - Ungheria 3
JO - Giordania 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
PY - Paraguay 3
SI - Slovenia 3
TH - Thailandia 3
AL - Albania 2
BH - Bahrain 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
IL - Israele 2
IR - Iran 2
LK - Sri Lanka 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CL - Cile 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MM - Myanmar 1
NA - Namibia 1
NG - Nigeria 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.388
Città #
Singapore 433
San Jose 280
Ashburn 243
Hong Kong 211
Fairfield 186
Rome 184
Chandler 165
Milan 101
Los Angeles 94
Beijing 86
Seattle 85
Santa Clara 75
Ho Chi Minh City 70
Woodbridge 70
Houston 69
The Dalles 65
Wilmington 64
Hanoi 49
Cambridge 46
Munich 43
Princeton 43
Tokyo 43
Lauterbourg 42
Johannesburg 36
Naples 36
Frankfurt am Main 35
Dallas 34
Helsinki 33
Hillsboro 33
San Paolo di Civitate 32
Buffalo 31
Turku 31
Millbury 30
Plano 28
Bari 27
Florence 26
São Paulo 25
Lawrence 24
Toronto 24
Turin 24
New York 23
Casablanca 21
Cosenza 21
Bengaluru 20
Ann Arbor 19
Palermo 19
Redondo Beach 19
Bologna 17
Boston 16
Bremen 16
San Diego 16
Lomé 15
Sofia 15
Dublin 14
Moscow 13
Venice 13
Columbus 11
Ottawa 11
Andover 10
Catania 10
Chicago 10
Falkenstein 10
Montreal 10
Orem 10
Biên Hòa 9
Boardman 9
Des Moines 9
London 9
Norwalk 9
Atella 8
Carmarthen 8
Haiphong 8
Jakarta 8
Miami 8
Paris 8
Phoenix 8
Rio de Janeiro 8
Birkenhead 7
Changsha 7
Federal 7
Genoa 7
Kuala Lumpur 7
Nairobi 7
Nuremberg 7
Rudiano 7
Stockholm 7
Taranto 7
Vienna 7
Amsterdam 6
Baghdad 6
Belo Horizonte 6
Brooklyn 6
Pescara 6
Poplar 6
Rimini 6
Ankara 5
Arluno 5
Brasília 5
Brussels 5
Da Nang 5
Totale 3.868
Nome #
Esperienza con l'imatinib ad intermittenza nei bambini e adolescenti con leucemia mieloide cronica (LMC): risultati e prospettive 384
Terapia con Idrossiurea in bambini e adolescenti affetti da anemia falciforme nel “real life setting 358
LOCALIZZAZIONE EXTRAMIDOLLARE DI LAM IN ETÀ PEDIATRICA: IL RUOLO DI UNA CORRETTA E TEMPESTIVA DIAGNOSI 209
EFFICACIA DEL PEG-IFNΑ-2A IN UN CASO DI POLICITEMIA VERA PEDIATRICA 196
Treatment-free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia. 171
EFFICACIA E SICUREZZA DELL’IMPIEGO DEI PICC IN PAZIENTI PEDIATRICI AFFETTI DA LEUCEMIA ACUTA: ESPERIENZA MONOCENTRICA 165
Atypical chronic myeloid leukemia in a patient with aplastic anemia 162
Reduced mortality from KPC-K.pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K.pneumoniae 159
Epstein-Barr virus–positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus–positive diffuse large B-cell lymphoma of the elderly 155
Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high-dose imatinib 148
Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience 148
INDOMETHACIN AS FIRST LINE TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS (LCH). A 20-YEAR EXPERIENCE OF A SINGLE CENTRE. 146
Intermittent Imatinib mesylate in children with chronic myeloid leukemia: results and outcome 143
Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience 140
Specific guidelines including multidisciplinary approach is critical of management of Langerhans Cell Histiocytosis in adults 139
Applicazione della classificazione WHO 2016 IN 80 bambini e adolescenti con neoplasie mieloproliferative croniche 138
Proven Epstein-Barr encephalitis with negative EBV-DNA load in cerebrospinal fluid after allogeneic hematopoietic stem cell transplantation in a child with acute lymphoblastic leukemia 135
Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy. results from a monoinstitutional cohort analysis of long-term survivors 133
Management of Chronic Myeloid Leukemia in children and adolescents according to local guidelines the Italian experience 126
Autoimmune Hemolitic Anemia in a Boy With Inactive Ulcerative Colitis 126
Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up succesfully treated with chemotherapy alone 121
Trombocitopenia Idiopatica (ITP) cronica. cosa puo’ nascondere? 112
Severe rituximab-induced pneumonitis in an immunocompromised child with acquired thrombotic thrombocytopenic purpura 112
Early Response Does Not Impact on the Long-Term Outcome of Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. The Italian Experience. 111
Chronic Thrombocytopenia in Children: What Could It Hide? 111
UTILITA’ DELLA TECNICA NEXT GENERATION SEQUENCING (NGS) NELL’IDENTIFICAZIONE DI GENI NON-DRIVER IN PAZIENTI CON MALATTIE MIELOPROLIFERATIVE CRONICHE (MMC) PEDIATRICHE WILD TYPE: ESPERIENZA DI UN SINGOLO CENTRO 110
A long-term outcome for patients with high-risk leukemia undergoing an unrelated cord blood transplant (CBT) 110
Long-term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib. The Italian Experience. 109
Response to High Dose Imatinib and Long-Term Outcome in Children and Adolescents with Previously Untreated Chronic Myeloid Leukemia in Chronic Phase. the Italian Experience. 109
Polyostotic Fibrous Dysplasia Mimicking Bone Involvement in Hodgkin Lymphoma: A Pediatric Case and Literature Review 109
Next-Generation Sequencing (NGS) in childhood Myeloproliferative Diseases (MPD) 107
Iron deficiency in children and adolescents: an alarm bell for gastrointestinal diseases. 105
EFFICACY OF INDOMETHACIN AS SALVAGE THERAPY IN CHILDREN AND ADULTS WITH LANGERHANS CELL HISTIOCYTOSIS WITH BONE INVOLVEMENT 101
Incidence and outcome of infections after unrelated cord blood transplantation in patients with hematological malignancies: a long-term single center experience 101
Managing Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. The Italian Experience. 99
P1580: MANAGEMENT OF PATIENTS WITH MASTOCYTOSIS DURING THE COVID-19 PANDEMIC: A SINGLE CENTER EXPERIENCE 99
Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukaemia 97
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study 90
Discontinuation of Imatinib (IM) in pediatrica chronic myeloid leukemia (CML) patients with sustained complete molecular remission (CMR). 85
Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL) 85
Primary Trombocythemia in Children and Adolescents Includes Different Subtypes Compared to Adult Essential Thrombocythemia 84
Acquired thrombotic thrombocytopenic purpura in a child: Rituximab to prevent relapse. A pediatric report and literature review 82
Fifteen years of iodine prophylaxis in Italy. Results of a nationwide surveillance (Period 2015-2019) 81
WHO 2016 classification in 80 children and adolescents with chronic myeloproliferative neoplasms 81
LAL PH+ IN ETÀ PEDIATRICA: VALUTAZIONE DELLA MALATTIA MINIMA RESIDUA E RUOLO DELLA TERAPIA CON INIBITORI DELLA TIROSINCHINASI (TKI) 74
null 73
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ 68
null 68
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-Producing Klebsiella pneumoniae for Febrile Neutropenic Episodes in Colonized Children with Acute Leukemia—An 8-Year Retrospective Observational Study 67
null 64
Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO 62
Long-term results with the adapted LMB 96 protocol in children with B-cell non Hodgkin lymphoma treated in Iraq: comparison in two subsequent cohorts of patients 60
DONOR CELL ACUTE MYELOID LEUKEMIA WITH DEL(9q) IN A PEDIATRIC PATIENT OCCURRING 11 YEARS FROM TRANSPLANT FOR SEVERE APLASTIC ANEMIA 54
null 43
P981: NEXT GENERATION SEQUENCING (NGS): AN IMPORTANT TOOL TO CHARACTERIZE MYELOPROLIFERATIVE DISEASES IN CHILDREN 37
P1006: NEXT GENERATION SEQUENCING (NGS) IN PEDIATRIC MASTOCYTOSIS 31
null 27
Severe rituximab‐induced pneumonitis in an immunocompromised child with acquired thrombotic thrombocytopenic purpura 21
null 18
null 3
Totale 6.662
Categoria #
all - tutte 16.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.228


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 0 21 13
2021/2022419 20 18 21 26 66 27 6 35 32 23 71 74
2022/2023596 85 93 36 73 65 71 7 36 82 9 18 21
2023/2024557 34 44 40 39 50 28 34 33 19 99 54 83
2024/20251.550 86 140 60 76 115 79 97 67 193 128 106 403
2025/20262.668 293 107 218 187 422 159 343 138 356 280 165 0
Totale 6.662